Cadila Healthcare has decided to delist its shares from Ahmedabad Stock Exchange (ASE) in view of non-trading of the company's shares on the exchange for past many years.
The company's board, which met today, decided to delist equity shares of the company from ASE, Cadila Healthcare said in a filing to the BSE.
There are 20,47,48,520 equity shares listed with BSE and National Stock Exchange and hence there will not be any inconvenience to any of the shareholders in trading of the shares, it added.
The company will remain listed on BSE and NSE, Cadila said.
Headquartered in Ahmedabad, Zydus Cadila group has global operations in four continents spread across US, Europe, Japan, Brazil, South Africa and 25 other emerging markets.
The group's operations range from active pharmaceutical ingredients (API) to formulations, animal health products and 'cosmeceuticals'.
Cadila shares ended at Rs 1,749.60 apiece on BSE, down 1.60 per cent from previous close.
